Distinguished Scientist Award
Yu Wang
Westlake University, China
Yu Wang is a researcher affiliated with Westlake University, China, whose scholarly profile is associated with research in pan-vascular diseases and related biomedical areas. The supplied bibliometric profile records 61 documents, approximately 1,200 citations, and an h-index of 20. These indicators provide a quantitative view of publication activity and citation impact, while the interpretation of research quality should also consider the scientific significance, reproducibility, collaboration, and broader contribution of individual studies. [1]
Abstract
This article presents an academic recognition profile for Yu Wang of Westlake University, China, in connection with the Distinguished Scientist Award under the World Cell Biologist Awards. The profile summarizes the supplied bibliometric indicators, institutional affiliation, subject specialization, publication record, and research-impact information. With 61 documented publications, 1,200 citations, and an h-index of 20, the reported metrics indicate an established scholarly publication and citation record. [1] Research associated with Westlake University has included biomedical and vascular-related investigations, demonstrating the multidisciplinary environment in which contemporary cell and disease research is conducted. [2]
Keywords
Yu Wang; Distinguished Scientist Award; Westlake University; China; Pan-Vascular Diseases; Cell Biology; Vascular Biology; Biomedical Research; Research Impact; Scientific Publications; Citation Analysis; Research Recognition.
Introduction
Scientific recognition generally considers multiple dimensions of scholarly activity, including research productivity, methodological contribution, scientific influence, collaboration, and relevance to the development of a research field. Bibliometric measures such as publication counts, citation counts, and the h-index can provide useful descriptive evidence, although they are most appropriately interpreted alongside qualitative assessment. [1][2]
Research Profile
According to the supplied profile information, Yu Wang is affiliated with Westlake University in China and is associated with the subject area of Pan-Vascular Diseases. The reported Scopus Author ID is 57208729510, with 61 documents, 1,200 citations, and an h-index of 20. These values describe the researcher’s bibliometric profile at the time the supplied data were compiled and may change as databases are updated.
Research Contributions
Research connected with Westlake University has included studies examining endothelial and vascular mechanisms. For example, a published investigation involving Yu Wang examined changes in pancreatic cancer-associated endothelial cells and reported a mechanistic relationship involving RhoA expression. [3] Another study involving a Westlake University research team investigated magnetized red blood cells as a strategy for controlling embolic stroke in an experimental model, illustrating the intersection of cellular engineering and vascular medicine. [4]
Publications
The supplied profile records 61 documents. Because publication databases are continuously updated and researcher names may correspond to multiple authors, individual publications should be attributed using persistent identifiers and authoritative bibliographic records rather than name matching alone. The Scopus Author ID supplied for this profile provides a principal mechanism for distinguishing the record from other researchers with the same name.[3] [4]
Research Impact
The reported citation total of 1,200 and h-index of 20 provide quantitative indicators of scholarly visibility. Citation-based measures can help identify the extent to which published work has been referenced by subsequent research, but they do not independently establish scientific quality, originality, societal impact, or clinical significance. [3] [2]
Award Suitability
Based on the supplied information, Yu Wang presents several characteristics that may be relevant to consideration for a Distinguished Scientist Award. These include an established publication record, a reported citation count of 1,200, an h-index of 20, and a defined research focus in pan-vascular diseases. The profile also indicates an institutional affiliation with Westlake University, an institution with active research programs spanning biomedical and life-science disciplines.
Conclusion
Yu Wang’s supplied academic profile describes an established research record associated with Westlake University and the subject area of Pan-Vascular Diseases. The reported 61 documents, 1,200 citations, and h-index of 20 provide measurable indicators of publication activity and scholarly visibility. Research examples involving vascular and cellular mechanisms further illustrate the relevance of this research area to contemporary biomedical science. [5] [4]
External Links
References
- Elsevier. (n.d.). Scopus author details: Yu Wang, Author ID 57208729510. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57208729510
- C Weiwei, G Runlin, L Lisheng, Y Wang, et al. (2016). Outline of the report on cardiovascular diseases in China, 2014.
https://academic.oup.com/eurheartjsupp/article-abstract/18/suppl_F/F2/2197105
- Chen, Y., Jin, H., Wen, W., et al. (2025). Targeting RhoA expression with formononetin and salvianolic acid B to mitigate pancreatic cancer-associated endothelial cells changes. Journal of Ethnopharmacology.
https://doi.org/10.1016/j.jep.2024.118711
- Shi, P., et al. (2022). Precise control of embolic stroke with magnetized red blood cells in mice. The research article includes Yu Wang and identifies Westlake Laboratory of Life Sciences and Biomedicine, Westlake University, among the affiliations.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8850623/
- Y Wang, W Gu, W Wen, X Zhang. (2022). SERPINH1 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis.
https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.756094/full